[Newsmaker] Approval of South Korea’s 1st homegrown vaccine likely next week
According to pharmaceutical industry sources Friday, the Ministry of Food and Drug Safety has been considering the review process for SK Bioscience’s COVID-19 vaccine candidate GBP510 since the company submitted a request for the approval of its biologics license application under the name “SKYCovione” in April.
The Drug Ministry said it could not confirm when the approval would potentially take place at the moment, as the review process is currently underway.
“Regarding the COVID-19 vaccine, the government will swiftly announce its decisions to the public as soon as they are official. But it is difficult to give predictions on when SK Bioscience’s vaccine will be approved,” a ministry official said.
An SK Bioscience official told The Korea Herald that the company is hoping to get the government’s approval before the end of June, adding that its working group has been closely cooperating with the drug authorities, but no decision has yet been made.
SK Bioscience CEO Ahn Jae-yong previously laid out the goal of having the company’s vaccine approved by authorities within the first half of this year in an online press conference in March.
“At this point in time, when countries around the world are developing strategies to respond to the endemic phase of the COVID-19 global health crisis, SK Bioscience has reached the final stage of developing Korea’s first COVID-19 vaccine for the benefit of Korea and the world,” Ahn said.
SKYCovione is a recombinant protein-based COVID-19 vaccine candidate incorporated with GSK’s pandemic adjuvant. It was jointly developed by SK Bioscience and the Institute for Protein Design at the University of Washington and backed up by the Bill and Melinda Gates Foundation and Coalition for Epidemic Prevention and Innovation.
Prior to the submission, the drug developer announced that it had secured positive results from phase 3 clinical trials of SKYCovione. SK Bioscience conducted the last clinical trials in 4,037 people over the age of 18 at 16 medical institutions in South Korea, Thailand, Vietnam, New Zealand, Ukraine and the Philippines.
According to the company, the results confirmed that SKYCovione demonstrated immunogenicity superiority in comparison to Vaxzevria, the control vaccine jointly developed by Oxford University and AstraZeneca.
SK Bioscience said the results also demonstrated SKYCovione’s clinically acceptable safety profile, as most of the adverse reactions that took place after injection were mild or moderate.
The Korea Disease Control and Prevention Agency signed a purchase agreement with SK Bioscience to buy 10 million doses of SKYCovione in March.
The drug developer said it plans to apply its vaccine for the World Health Organization’s emergency use listing while looking to obtain authorization from other countries’ regulators to expand its reach to the global market.
(责任编辑:资讯)
相关内容
- “精致小春姐”顾春芳:华丽白西装、镶钻水晶拖鞋,带来新兴凉果No.1
- Govt mulls nine
- Park loyalists in Saenuri remain unmoved despite purge threat
- Rise of ‘Candle Citizens’ to reshape democracy in 2017
- 应对高温 户外驿站送清凉
- CPUs Don't Matter For 4K Gaming... Wrong!
- Acting president says S. Korea
- Croatia, South Korea, Finland into Davis Cup Finals
- 荥经地税 召开民主生活会
- Supercritical geothermal power: Limitless promise or impossible dream?
- MoviePass co
- Rise of ‘Candle Citizens’ to reshape democracy in 2017
- Minor presidential candidates call for expanding welfare
推荐文章
-
CPUs Don't Matter For 4K Gaming... Wrong!
Something we hear a lot these days, especially when it comes to CPU benchmarking, is that CPU perfor ...[详细] -
N. Korea holds Cabinet plenary meeting over grain output, economic issues
This photo, carried by North Korea's official Korean Central News Agency, Oct. 2, shows North Korean ...[详细] -
Why does North Korea use term 'puppet' to describe South Korea?
North Korean leader Kim Jong-un delivers a speech at the 9th session of the 14th Supreme People's As ...[详细] -
Chance the Rapper is catching major blowback for defending Kanye's 2020 'campaign'
Chance the Rapper publicly and repeatedly tweeted his support for Kanye West's presidential bid on M ...[详细] -
Haider all set for Paralympics Ceremony
PARIS:Pakistan's premier athlete at the Paralympics Haider Ali will be representing the country ...[详细] -
N. Korea denounces deadly drone attack in Syria
Women react during the funeral of members of the Kurdish Asayish security forces, killed a day earli ...[详细] -
Acting president says S. Korea
Acting President and Prime Minister Hwang Kyo-ahn said Tuesday the South Korea-Japan agreement clinc ...[详细] -
冻眠技术革新物流冷链体系,广州荔枝鲜销全球_南方+_南方plus日啖荔枝三百颗,不辞长作岭南人。如今,随着广东“百县千镇万村高质量发展工程”稳步推进,荔枝冷链物流体系愈发完善,从田头小站到物流网络的建 ...[详细]
-
U.S. Senators call on FTC to investigate the security of drivers' data
Carmakers are still putting diver data up for auction, and it's a practice that needs to be curbed, ...[详细] -
Stan the man claims Davis Cup win for Switzerland
PARIS:Stan Wawrinka took Switzerland to the Davis Cup Finals group stage on Saturday, winning a roll ...[详细]
热点阅读
随机内容